Two-thirds of enrollees had abnormal HbA1c (5.7-6.4%)
Rambhia has published numerous peer-reviewed articles in leading journals, including the Journal of the American Academy of Dermatology, Lasers in Surgery and Medicine, Dermatologic Surgery, International Journal of Dermatology, Journal of Clinical and Aesthetic Dermatology, Melanoma Research, and the International Journal of Clinical Oncology
reviews cases nationwide and provides free consultations to determine eligibility
While researching, though, many women stumble upon semaglutide (GLP-1 medication) and berberine (GLP-1 supplement)
The DEA has repeatedly extended these waivers
Semaglutide is an FDA-approved prescription medication that was initially developed to manage type 2 diabetes